You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more
9/ George’s last point re: kids: “In adults, we wonder where the MI’s went; pediatricians wonder where the kids went” when due for vaccines. Big fall in vaccinations; GR predicts we’ll soon see outbreaks of pertussis & measles. Ironic as we struggle desperately for Covid vaccine.pic.twitter.com/0sfBimeqgy
10/ Moving off peds, @ 20:10 I asked Rutherford about the interrelationship between distancing & masks. “I think masks are more important than social distancing… if I had to choose one, I’d choose masks.” “We’re trying to prevent asymptomatic people from transmitting…”
11/ @ 21:30: Early message in Covid was that masks only help others, but GR confirms they also help wearer – just not as much as they prevent transmission to others. It would be great if this message got out more – masks aren’t just an act of charity, they’re also self-interest.
12/ Finally, @ 23:50, I asked how much George worries about fomites. "It’s not as worrisome as somebody sneezing in your face, but you ignore it at your peril.” He’d worry about a metal rail in a public place (like a subway), but doesn’t fret re: touching shopping bags or mail.
13/ @ 24:50, @annieluet (Luetkemeyer) on treatments. Many candidates, 2 types of targets: antiviral vs. drugs that modify immune system. She makes point that combo Rx might be key. Theoretically, one from each category, but in HIV, turned out that multiple antivirals worked best.pic.twitter.com/ULFXx1MGTb
14/ @ 29:02: Remdesivir “isn’t easy to make.” @GileadSciences giving license to generic makers outside U.S. to ramp up production. There’s a nat'l shortage of Remdesivir (incl. in SF) – hospitals are developing triage rules, some using lotteries to decide who gets it. Troubling.pic.twitter.com/eDhRhJhffy
15/ We’re still waiting for better studies of Remdesivir, incl. to tell us if it’s useful in patients w/ milder disease, & if using it in combo w/ other drugs is helpful. Unfortunately, it’s IV only, which thwarts possibility of giving it earlier in course of illness (@ 41:06).
16/ @ 34:10, on use of interferon beta: hint of benefit when started early, yet no mortality benefit seen (but limited: trial had no deaths in treatment & control groups). @ 36:25, re: convalescent plasma: seems safe but still no evidence for mortality benefit. Studies ongoing.pic.twitter.com/0Ph0cuEXCF
17/ @ 37:35: Hydroxychloroquine: disappointing results to date. @ 44:22: I pushed Annie on whether we’d have shelved the drug by now if it wasn’t being pushed by Trump. She was equivocal, but agreed that – while there was some promise early – there is little to commend it now.pic.twitter.com/53fkKZUdMK
18/ Next, @ 46:42, vaccines w/ Joel Ernst. I had chatted w/ Joel on Mon https://bit.ly/3c0ba0V re @moderna_tx's early results. His new insights today: @ 48:50, while 8 out of 45 pts had neutralizing antibodies, he clarifies that others weren’t neg; they haven’t been reported yet
19/ @ 52:20: The @moderna_tx is RNA vaccine: there’s no RNA vaccine in use today (it’s based on v. modern technology). This increases risk that there'll be a surprise problem.
@ 53:10, next step in testing Moderna vaccine is expanding safety trial to 600 pts, incl. pts >age 55
20/ @ 56:00, Joel gives more details on the two ways of testing vaccine efficacy: a population-based study vs. a human challenge. He also notes that some vaccines block infections; other effective vaccines just attenuate the illness rather than completely blocking infection.
21/ @ 1:01;05: even if everything goes perfectly in further tests of @moderna_tx vaccine, Ernst thinks we’re still at least a year away from routine availability for high-risk populations. And, to produce billions of doses for everybody, add some time on time on top of that.
22/ Final topic, @ 1:03:00, Andy Leavitt on thromboembolic complications (aka “Covid-Associated Coagulopathy”). It’s the real deal, and “we don’t understand it mechanistically.” It’s not just a form of DIC (a fairly common bleeding/clotting abnormality in very sick patients).
23/ @ 1:13:30, in French study of 150 pts, 64 had significant thrombosis, even though all were getting VTE prophylaxis.. This is astounding. Most amazing: high rate (96%) of clotting the circuit when patients were getting renal support; this is simply not seen in other diseases.pic.twitter.com/Q0Uz48wgl5
24/ @ 1:20:00, Leavitt recommends higher dose of anticoagulation than usual, but doesn’t recommend therapeutic-dose anticoag for Covid pt without clot. Nor would he recommend anticog or aspirin for outpatients with Covid. The clots are scary, but anticoagulation is risky as well.
25/ Another great grand rounds; watch if you can https://bit.ly/3bTcpP9 . Clinically, Covid is wild. Kids don’t get too sick (good), but now there's MIS-C (bad). & bizarre clots. Covid is relentless teacher of clinical medicine. And it's not the flu. Back tomorrow. Stay safe.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
